Prefilled Syringes Market Size, Share, Competitive Landscape and Trend Analysis Report, by Material, Design, Therapeutic and Application : Global Opportunity Analysis and Industry Forecast, 2021-2030

Prefilled Syringes Market Statistics 2030:

The global prefilled syringes market size was valued at $5,620.23 million in 2020, and is projected to reach $15,735.49 million by 2030, registering a CAGR of 10.8% from 2021 to 2030. A prefilled syringe is a single-dose packet of vaccine to which a needle has been fixed by the manufacturer. In the past, metal or glass syringes were popular, but increasingly there has been a movement toward plastic and disposable syringes so the needle is protected and cannot be re-used (prefilled disposable systems). This has stimulated the demand for convenient and safe prefilled syringes in the medical field over conventional glass vials for packing parental drugs.

The prefilled syringes reduce the risk of drug contamination as when a syringe is inserted into a drug vial to draw out a dose; it represents another potential admixture-related contamination risk. Elimination of this risk with a pre-sterilized syringe increases safety and removes the additional process of on-site vial cleaning and de-pyrogenation.

The growth of the prefilled syringes market is driven by the growth in home-based healthcare market, increase in adoption of injectable drugs, rise in incidence rate of chronic diseases, surge in benefits of using prefilled syringes over conventional vials. Moreover, technological advancements related to the prefilled syringes contributes toward the growth of the market. However, stringent government regulations, availability of alternative drug-delivery methods, and product recalls are expected to hinder the market growth. Conversely, the growth of biologics & biosimilars and increase in demand for injectable drugs in prefilled forms offer lucrative opportunities for growth of the market.

Impact Of Covid-19 On Prefilled Syringes Market (Pre And Post Analysis)

Coronavirus (COVID-19) outbreak started in late December in Hubei province of Wuhan city in China. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) this virus is transmitted among humans. There is rise in the demand for the prefilled syringes over glass ampoules or any other additional needles due to the reduced risk of needle-stick injuries. Therefore, to increase the production of COVID-19 vaccine, the manufacturers have increased the production capacity of the prefilled syringes. For instance, the U.S. government has signed a deal of $138 million with the syringe makers to facilitate the production of 100 million prefilled syringes for the COVID-19 vaccines by the end of 2020.

The market players have increased the investment in raw materials and resources owing to the rise in demand for home based healthcare services. Health care professionals have responded to new and varied ways of delivering the appropriate quantity of care by embracing telemedicine, which helps to reduce face-to-face interaction. The increased role of community and individual pharmacists in the management of chronic conditions, as well as the promotion of medication adherence during the COVID-19 pandemic outbreak has eased the burden of healthcare systems. Overall, the impact of COVID-19 on the prefilled syringes market was recorded to be fairly positive. This was attributed to rise in the demand for prefilled syringes over glass ampoules or any other additional needles. Moreover, the market players have increased the investment in raw materials and resources owing to rise in demand for home based healthcare services.

The prefilled syringes market is segmented on the basis of material, design, therapeutic, application, and region. Based on material, the market is categorized into glass-based and plastic-based. By design, it is classified into single-chamber prefilled syringes, dual-chamber prefilled syringes, customized prefilled syringes. Depending on therapeutic, it is bifurcated into large molecules, small molecules. Depending on application, it is fragmented into anaphylaxis, rheumatoid arthritis, diabetes, and others (cancer, multiple sclerosis and others). Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Material segment review

Based on the material, the global prefilled syringes market is classified into glass-based and plastic-based. Glass-based segment was the major contributor to the global market in 2020, and is anticipated to remain dominant during the forecast period, due to technological advancements in the prefilled syringes, increase in adoption of prefilled syringes, rise in incidence rate of chronic diseases and increase in benefits of using prefilled syringes over conventional vials.

Design segment review

Based on the design, the global prefilled syringes market is classified into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. Single-chamber prefilled syringes segment was the major contributor to the global market in 2020, and is anticipated to remain dominant during the forecast period, due to increase in the demand for prefilled syringes, increase in the number of benefits from the prefilled syringes, and surge in the prevalence of chronic diseases.

Therapeutic Segment Review

Based on therapeutic, the global prefilled syringes market is divided into large molecules and small molecules. Small molecules segment is expected to register the highest growth rate during the forecast period. However, large molecules segment dominated the global market in 2020, and is anticipated to continue this trend throughout the forecast period. This is attributed to increase in the adoption of injectable drugs, growth in home-based healthcare market, and rise in the use of prefilled syringes.

Application Segment Review

Based on application, the global prefilled syringes market is divided into anaphylaxis, rheumatoid arthritis, diabetes, and others (cancer, multiple sclerosis, and others). The diabetes segment was the major contributor to the global market in 2020, and is anticipated to remain dominant during the forecast period, due to rise in adoption of injectable devices, surge in advantages of prefilled syringes, and increase in prevalence of chronic diseases.

Region Segment Review

Europe accounted for major share of the global prefilled syringes market share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidences of chronic disease, surge in demand for prefilled syringes, availability of advanced healthcare facilities with trained medical professionals, rise in number of R&D activities coupled with large presence of key players, and surge in investment made by governments in the healthcare system. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period. Moreover, India and Rest of Asia-Pacific countries are expected to grow at high CAGR in Asia-Pacific prefilled syringes market majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced instruments, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of prefilled syringes.

Key Benefits For Stakeholders

• This report provides a detailed quantitative analysis of the current prefilled syringes market trends and forecast estimations from 2020 to 2030, which assists to identify the prevailing market opportunities. 
• An in-depth prefilled syringes market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
• A comprehensive analysis of factors that drive and restrain the growth of the global the prefilled syringes market is provided.
• The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2030, in terms of value.
• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
• Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook of the prefilled syringes market.

  Prefilled Syringes Market Report Highlights

Aspects	Details
By Material	Glass-based Plastic-based
By DESIGN	Single-chamber Prefilled Syringes Dual-chamber Prefilled Syringes Customized Prefilled Syringes
By THERAPEUTICS	Large Molecules Small Molecules
By APPLICATION	Anaphylaxis Rheumatoid Arthritis Diabetes Others (Cancer, Multiple Sclerosis, and Others)
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, Rest of Europe) Asia Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players	BAXTER INTERNATIONAL, BAYER AG, WEST PHARMACEUTICAL SERVICES, INC., TERUMO MEDICAL CORPORATION, NIPRO CORPORATION, MEDTRONIC PLC, ABBOTT LABORATORIES, VETTER PHARMA INTERNATIONAL GMBH, BECTON, DICKINSON AND COMPANY, GERRESHEIMER AG

Analyst Review

The prefilled syringes market is expected to witness a steady growth in the future. The market has drawn the interest of the healthcare industry, owing to an increase in prevalence of chronic diseases globally.

The prefilled syringes market is dominated by well-established players; hence, there is intense competition in the global market. Prefilled syringes contain fixed doses of drugs that can be either self-administered by the patient or can be used by the healthcare professionals. These syringes have gained acceptance in the market as drug delivery systems for injectable drugs. They are preferred for parenteral administration of various drugs and are used for the treatment of chronic diseases where self-administration of drugs by the patients is required.

The advantages of using prefilled syringes, such as reduced risk caused by using vials before use of drugs, ease of use, decreased risk of contamination, and elimination of dosing errors have largely contributed toward their increase in demand among the healthcare professionals. Moreover, rise in demand for home-based healthcare products, surge in incidence of chronic diseases, and increase in adoption of injectable drugs are anticipated to boost the market growth.

The use of prefilled syringes is highest in Europe, owing to the maturity of the market, increase in adoption of these products, high prevalence rate of chronic diseases, and rise in disposable income among customers. Although the use of prefilled syringes in Asia-Pacific and LAMEA is low, the adoption rate is expected to increase, owing to surge in disposable income, increase in incidence rate of chronic disease, and presence of large geriatric population

Author Name(s) : Sushant Terdale| Avinash Gadekar | Roshan Deshmukh

Related Tags

• Drug Delivery
• Surgical Equipment
• Pain Management
• Medical Tourism
• Cancer Therapy

^*Terms and Conditions Apply